We suggest that the prolonged stress associated with PTX treatment stimulates the p38 MAPK/p53 network and induces EGFR transcription, which activates the EGFR pathway and PTX resistance in NSCLC. The gene discussed is TP53; the disease is non-small cell lung carcinoma.